- Home
- USIO vs MYO Comparison
USIO vs MYO Comparison
Compare USIO & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USIO | MYO |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.1M | 39.2M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | USIO | MYO |
|---|---|---|
| Price | $1.35 | $0.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $4.00 | ★ $7.67 |
| AVG Volume (30 Days) | 72.5K | ★ 758.1K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $83,710,461.00 | $41,643,203.00 |
| Revenue This Year | $5.99 | $24.07 |
| Revenue Next Year | $11.65 | $17.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 1.46 | ★ 65.00 |
| 52 Week Low | $1.24 | $0.71 |
| 52 Week High | $2.92 | $7.17 |
Technical Indicators
Market Signals| Indicator | USIO | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 42.90 | 47.47 |
| Support Level | $1.41 | $0.92 |
| Resistance Level | $1.37 | $1.05 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 17.11 | 13.29 |
Price Performance
Historical ComparisonAbout USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).